The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
BridgeBio Pharma, Inc(NASDAQ:BBIO) 
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs inc...
Website: http://www.bridgebio.com
Founded: 2015
IPO Price: $17 (Jun 27, 2019)
Full Time Employees: 369
CEO: Neil Kumar
Sector: Healthcare
Industry: Biotechnology
BridgeBio Pharma Days Payable Outstanding ttm (DPO)
BridgeBio Pharma Days Receivable Outstanding ttm (DSO)
BridgeBio Pharma Days Inventory Outstanding ttm (DIO)
BridgeBio Pharma Op Cashflow Per Share ttm
BridgeBio Pharma Free Cashflow Per Share ttm
BridgeBio Pharma Cash Per Share ttm
BridgeBio Pharma P/S ratio ttm
BridgeBio Pharma (GAAP) P/E ratio ttm
BridgeBio Pharma P/B ratio ttm
No extra charts and metrics for this ticker.